IL-33 modulates inflammatory brain injury but exacerbates systemic immunosuppression following ischemic stroke

Abstract

Stroke triggers a complex inflammatory process in which the balance between pro- and antiinflammatory mediators is critical for the development of the brain infarct. However, systemic changes may also occur in parallel with brain inflammation. Here we demonstrate that administration of recombinant IL-33, a recently described member of the IL-1 superfamily of cytokines, promotes Th2-type effects following focal ischemic stroke, resulting in increased plasma levels of Th2-type cytokines and fewer proinflammatory (3-nitrotyrosine+F4/80+) microglia/macrophages in the brain. These effects of IL-33 were associated with reduced infarct size, fewer activated microglia and infiltrating cytotoxic (natural killer-like) T cells, and more IL-10-expressing regulatory T cells. Despite these neuroprotective effects, mice treated with IL-33 displayed exacerbated post-stroke lung bacterial infection in association with greater functional deficits and mortality at 24 hours. Supplementary antibiotics (gentamicin and ampicillin) mitigated these systemic effects of IL-33 after stroke. Our findings highlight the complex nature of the inflammatory mechanisms differentially activated in the brain and periphery during the acute phase after ischemic stroke. The data indicate that a Th2-promoting agent can provide neuroprotection without adverse systemic effects when given in combination with antibiotics.

AIM2 Inflammasome Mediates Hallmark Neuropathological Alterations and Cognitive Impairment in a Mouse Model of Vascular Dementia

“…Our data are consistent with a role of AIM2 in these brain resident cells and regions, but we cannot exclude circulating leukocytes as another possible cell mediating the pro-inflammatory actions of AIM2 in the brain in chronic hypoperfusion. Leukocytes contribute to other forms of brain injury and neurodegeneration 57–59 and their infiltration from the circulation would be expected in association with reduced blood-brain barrier integrity and blood vessel density known to occur in hypoperfusion-induced VaD 60 . However, in this study we have not assessed the role of leukocyte infiltration and related neutrophil extracellular traps (NETs), known as NETosis, as a potential source of AIM2 ligand.…”

Peripheral Administration of IL-13 Induces Anti-inflammatory Microglial/Macrophage Responses and Provides Neuroprotection in Ischemic Stroke

“…There is an increasing evidence that induction of Th2-type immune response has neuroprotective effects following stroke by limiting progression of the ischemic infarct [49][50][51][52]. However, repetitive administration of M2 cytokines after ischemic stroke can enhance the post-stroke immunosuppression, thereby facilitating bacterial infections and increasing mortality [53,54]. In our study, we used a single dose of IL-13 in a pMCAo model that produces strictly cortical lesions.…”

The immune system and psychiatric disease: a basic science perspective

“…We recently found that the IL‐1 family cytokine IL‐33 made by astrocytes physiologically regulates microglial synapse elimination . This homeostatic function is distinct from its reparative role in the context of injury , Alzheimer's disease and ischemic stroke . Another IL‐1 family member, IL‐18, is also locally expressed in the brain, including in the emotion and threat regulating centers in the basolateral amygdala and has been proposed to mediate behavioral responses to chronic stress .…”